Important Information For US Residents

In the United States, the INTERCEPT Blood System for plasma has received FDA approval, and the INTERCEPT Blood System for platelets is under regulatory review.

For more information on the development status of the INTERCEPT Blood System, please access the Cerus Corporation website.

 

 

 

 

 

 

Untitled Document